| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 09/12/2008 | WO2008108260A1 Light-emitting device |
| 09/12/2008 | WO2008108256A1 Light-emitting device material and light-emitting device |
| 09/12/2008 | WO2008073461A3 Ion channel modulators |
| 09/12/2008 | CA2678895A1 Tricyclic compounds useful in treating iron disorders |
| 09/11/2008 | US20080221215 Antiviral inhibition of capsid proteins |
| 09/11/2008 | US20080221206 less anesthetic activity, but with more anti-inflammatory and spasmolytic activity; asthma, rhinitis, allergic urticaria, chronic lung inflammation associated with eosinophilia, following the example of atopic asthma and chronic intestinal inflammation, as colitis for instance |
| 09/11/2008 | US20080221205 effect on bone proliferation with the side effect reduced; degenerative bone disease and rheumatoid arthritis |
| 09/11/2008 | US20080221191 Mycobacterium tuberculosis infection; protozoan pathogens; fungal pathogens |
| 09/11/2008 | US20080221082 of the alpha V beta 3 integrin receptor; , thromboembolic events, cardiovascular disorders, lung diseases, disorders of the CNS, the kidney, the gastrointestinal tract or inflammation |
| 09/11/2008 | US20080220285 Derivatives of fused aromatic systems; sublimation stability; easy to purify due to better solubilty; easy reproducibility because do not form isomers; high efficiency and high stability on use in organic electroluminescent devices |
| 09/11/2008 | US20080217585 Lactone stabilizing compositions |
| 09/11/2008 | US20080217580 Organic Luminescent Element |
| 09/10/2008 | EP1966179A2 Darifenacin hydrobromide composition substantially free of oxidized darifenacin and salts thereof and processes for the preparation thereof |
| 09/10/2008 | EP1966135A2 3'-alkoxy-spirocyclopentyl-substituted tetramic and tetronic acids |
| 09/10/2008 | EP1966127A1 Carbonyl asymmetric alkylation |
| 09/10/2008 | EP1965832A1 Gastrointestinal function promoter |
| 09/10/2008 | EP1965807A2 S1p receptor modulating compounds and use thereof |
| 09/10/2008 | EP1301474B1 Tyrosine derivatives as phosphatase inhibitors |
| 09/10/2008 | EP1294705B1 Synthesis of cyclic compounds |
| 09/10/2008 | CN101260099A Method for preparing antineoplastic effective composition bullatacin |
| 09/10/2008 | CN101260098A Technique for preparing potassium sodium dehydroandroandrographolide succinate |
| 09/10/2008 | CN101260097A Technique for preparing potassium sodium dehydroandroandrographolide succinic by using potassium dehydroandrographolide succinate |
| 09/10/2008 | CN101260096A Exact filtration for refining furfuryl alcohol, continuous distillation composite technique and device for the same |
| 09/10/2008 | CN101260095A 13-halo-3,15-dioxygibberellic acid ester and preparation method thereof |
| 09/10/2008 | CN101259154A Effective component of ligusticum chuanxiong, saposhnikovia divaricata, dahurian angelica root for treating vascular diseases and its components compatibility formula |
| 09/09/2008 | US7423185 Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof |
| 09/09/2008 | US7423181 Aminoalkoxy-functional chalcones |
| 09/09/2008 | US7423154 Asymmetric process for the preparation of diarylethylpiperazines derivatives and novel asymmetric diarylmethylamines as intermediates |
| 09/09/2008 | US7423067 Diphenyl cyclopentyl amides as cannabinoid-1 receptor inverse agonists |
| 09/09/2008 | US7423057 Dihydroorotate dehydrogenase (DHODH) inhibitors; Rheumatoid arthritis, Pneumocystis carinii, fibrosis, uveitis, rhinitis, asthma, and athropathy; 2-(Biphenyl-4-ylcarbamoyl)-cyclopent-1-enecarboxylic acid |
| 09/09/2008 | CA2211646C Substituted phenyl compounds as endothelin antagonists |
| 09/04/2008 | WO2008106179A1 Intermediates and processes for the synthesis of ramelteon |
| 09/04/2008 | US20080214846 (S)-2-{1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidinyl}-2,2-diphenylacetamide, selective muscarinic acetylcholine receptor antagonists, used for treating urogenital disorders such as incontinence |
| 09/04/2008 | US20080214841 High-purity biphenyltetracarboxylic dianhydride and process for producing the same |
| 09/04/2008 | US20080214838 Oligo-Tetracenes, Production and Use Thereof |
| 09/04/2008 | US20080214673 e.g. Furan-3-carboxylic acid [(1R,3R)-3-(3-chloro-phenylethynyl)-3-hydroxy-cyclohexyl]-amide; metabotropic glutamate receptors modulator/antagonist;anxiolytic agent, antidepressant; amidation of amine-compounds |
| 09/04/2008 | US20080214661 Process To Obtain Dibenzylbutyrolactonic, Tetrahydrofuranic Lignans And Their Synthetic And Semi-Synthetic Derivatives, Their Analgesic And Anti-Inflammatory Activities, Topical And/Or Systemic Formulations Containing Said Lignans And Their Respective Therapeutic Method |
| 09/04/2008 | US20080214660 Compounds and Methods for the Inhibition of the Expression of VCAM-1 |
| 09/04/2008 | US20080214655 Paclitaxel or a paclitaxel analog and 2,5-Dimethoxythiobenzoic acid N-methylhydrazine; antitumor; nontoxic |
| 09/04/2008 | US20080214635 Modulation of pathogenicity |
| 09/04/2008 | US20080213439 Distilling a medium containing internal dehydration product to obtain a distillate enriched with this product, purifying; contacting with stabilizing agent; shaping the resulting internal dehydration product of a hydrogenated sugar |
| 09/03/2008 | EP1964561A1 Inhibitors of IMPDH enzyme |
| 09/03/2008 | EP1963280A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators |
| 09/03/2008 | EP1963262A2 N-hydroxyamide derivatives possessing antibacterial activity |
| 09/03/2008 | EP1893595B1 Preparation of (s)-4-fluoromethyl-dihydro-furan-2-one |
| 09/03/2008 | EP1412342B1 Process for the production of beraprost and its salts |
| 09/03/2008 | CN101258139A Method for preparing 3-hydroxyl phthalic anhydride |
| 09/03/2008 | CN101255147A Spiromesifen derivative as well as synthesis and use thereof |
| 09/03/2008 | CN101255146A 5/7/6 type 13(15) site epoxy taxane diterpenoid, medicament combination and uses thereof |
| 09/03/2008 | CN101255145A Method for preparing mycophenolate mofetil |
| 09/03/2008 | CN101255144A Preparation of ascorbyldehydroabietate assistant by ultrasound wave |
| 09/03/2008 | CN101254475A Homogeneous process for the hydrogenation of carboxylic acids and derivatives thereof |
| 09/03/2008 | CN100415750C Fungicides for the control of take-all disease of plants |
| 09/03/2008 | CN100415730C Benzofuran derivative and its preparation and use |
| 09/03/2008 | CN100415729C 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 09/03/2008 | CN100415227C Use of compounds in preparing medicament for treating treating transplant rejection |
| 09/02/2008 | US7420089 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |
| 09/02/2008 | US7420087 Method for preparing 4-hydroxyisoleucine diastereoisomers and enantiomers and derivatives thereof |
| 09/02/2008 | US7420070 Resolution with acid; salt formation, cyclization |
| 09/02/2008 | US7420069 Crystalline composition containing escitalopram |
| 09/02/2008 | US7420068 Crystals of purified escitalopram oxalate with a broad particle size distribution suitable for use in direct compressionproduced by treating a solution of citalopram with a hydroxyl group scavenger and reacting with oxalic acid; refluxing, cooling, salt formation, seeding, filtration |
| 09/02/2008 | US7420067 Heating a sugar alcohol in the presence of an acid catalyst, followed by purification such as by vacuum distillation and melt crystallization; organic solvent-free; isosorbide from sorbitol for example |
| 09/02/2008 | US7420066 Benzofuran derivatives useful for treating hyper-proliferative disorders |
| 09/02/2008 | US7420065 Hetero-polycyclic compounds, and coloring matters, pigments, dyes, color-changing material compositions, and color-changing films, made by using the compounds |
| 09/02/2008 | US7420061 Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors |
| 09/02/2008 | US7420001 N-({4'-[(1-benzofuran-2-ylcarbonyl)amino]-1,1'-biphenyl-4-yl}sulfonyl)glycine; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis |
| 09/02/2008 | US7419986 Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans |
| 09/02/2008 | US7419980 Treating conditions improved by monoamine reuptake; 1-[1-(2-naphthyl)-2-piperazin-1-ylethyl]cyclobutanol; sexual disorders, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders, hot flashes |
| 09/02/2008 | US7419967 e.g. hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-3-(cyclopentyloxy)[(3-[2-(dimethylamino)ethyl]aminophenyl)sulfonyl]amino-2-hydroxypropyl)carbamate; against human immunodeficiency virus, chronic and acute viral infections |
| 09/02/2008 | US7419933 chiral zirconium catalyst that can maintain its high catalytic activity even after long-term storage, which is stable in air and storable for a long period of time, and recoverable and reusable after reaction, is provided. |
| 09/02/2008 | CA2360864C Process for the preparation of 3,4-dihydroxybutanoic acid and derivatives thereof from substituted pentose sugars |
| 09/02/2008 | CA2273023C Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 09/02/2008 | CA2248338C 2-amino-4-bicycloamino-1,3,5-triazines as herbicides and plant growth regulators |
| 08/28/2008 | WO2008102881A1 ANALOGUE OF MAPKK NUCLEAR EXPORT INHIBITOR peumusolide A AND USE THEREOF |
| 08/28/2008 | WO2008102232A1 Benzofuran antiparasitic agents |
| 08/28/2008 | US20080207925 Distillation purification ; discharging low boiling compounds |
| 08/28/2008 | US20080207924 by gas phase oxidation of o-xylene and/or naphthalene; TiO2 on support; improvement in activity, selectivity and lifetime of the catalyst; BET surface area is more than 15 m2/g; 60 and 400 nm pore size; primary crystal size is more than 22 angstrom |
| 08/28/2008 | US20080207921 purified polylactic acid or glycolic acid-lactic acid copolymer; insert for drugs |
| 08/28/2008 | US20080207847 Reaction product of aromatic diamine with 2,5-dicarboxylic furan; for polyureas, polyurethanes elastomers; chain extransion; reaction injection molding; controlling cure time |
| 08/28/2008 | US20080207734 Novel alkoxylactones, alkoxylactams and alkoxythiolactams for controlling processes based on microbial interaction |
| 08/28/2008 | US20080207728 Bicyclic acyltryptophanols |
| 08/28/2008 | US20080207701 Opioid receptor antagonists |
| 08/28/2008 | US20080207636 Using a benzmide compound; antidiabetic agents; obesity |
| 08/28/2008 | US20080207576 Substituted sapogenins and their use |
| 08/28/2008 | US20080206322 Advantageous properties when administered orally; consistency of pharmacokinetic behavior achieved; exhibits less fatty food interaction; time release coating reduces variation in mycophenolic acid exposure from one day to the next or from day time to night |
| 08/28/2008 | CA2678149A1 Benzofuran antiparasitic agents |
| 08/27/2008 | EP1962354A1 Organic electroluminescence element material and organic electroluminescence element using same |
| 08/27/2008 | EP1960379A1 N-(1-alkyl-2-phenylethyl)-carboxamide derivatives and use thereof as fungicides |
| 08/27/2008 | EP1960378A1 A manufacturing process of 2',2'-difluoronucleoside and intermediate |
| 08/27/2008 | EP1960355A1 3-amino-1-arylpropyl indoles and aza-substituted indoles |
| 08/27/2008 | EP1960352A1 2-adamantylurea derivatives as selective 11beta-hsd1 inhibitors |
| 08/27/2008 | EP1606275B1 Opioid receptor antagonists |
| 08/27/2008 | EP1408036B1 Process for producing benzofuran derivative |
| 08/27/2008 | EP1406895B1 Lactone formulations and method of use |
| 08/27/2008 | EP1368325B1 New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates |
| 08/27/2008 | EP1200390B1 Production of n-substituted 2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoylamides |
| 08/27/2008 | CN101253147A Organic compounds |
| 08/27/2008 | CN101250174A Spiromesifen derivative as well as synthesis and use thereof |
| 08/27/2008 | CN101250173A Preparation method of spiromesifen |
| 08/27/2008 | CN101250172A Arginine double-protective preparation technique |